Related Experiment Video
Updated: Feb 17, 2026

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
Published on: March 17, 2012
Neurobrucellosis presenting as clinically definite amyotrophic lateral sclerosis
Andreas A Argyriou1, Panagiotis Karanasios1, Apostolos Papapostolou2
1a Department of Neurology , "Saint Andrew's" State General Hospital of Patras , Patras , Greece.
Abstract:
Purpose/Aim: We describe the first case of a patient with neurobrucellosis presenting with clinically-definite ALS.
Material And Methods:
A 48-year old male patient, in whom the diagnoses of systemic brucellosis and clinically definite ALS were undoubtedly confirmed and were eventually causally interrelated. The disease-specific antibiotic therapy was unsuccessful to slow the evolution of the motor neuron disease and the patient became non ambulatory over time.
Results:
Considering the close temporal association of ALS onset with the systemic Brucella infection and consequent antigenic stimuli, we might suggest that human brucellosis might have triggered a process of motor neuron degeneration in keeping with neurobrucellosis, primarily due to parainfectious mechanism.
Conclusion:
Our case helps to shed light on the factors that may trigger or only fasten motor neuron disease manifestations.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Parkinson's Disease: Overview
Cross-bridge Cycle
Neural Regulation

